Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Jun. 2025,
CI Medical Co paid円0 Mil more to buy back shares than it received from issuing new shares.
It spent円14,291 Mil paying down its debt.
It paid円0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spent円626 Mil paying cash dividends to shareholders.
It spent円6 Mil on other financial activities.
In all, CI Medical Cospent円14,923 Mil on financial activities for the
six
months ended in Jun. 2025.
CI Medical Co (TSE:3540) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
CI Medical Co's issuance of stock for the
six
months ended in Jun. 2025 was 円0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
CI Medical Co's repurchase of stock for the
six
months ended in Jun. 2025 was 円0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
CI Medical Co's net issuance of debt for the
six
months ended in Jun. 2025 was 円-14,291 Mil.
CI Medical Co spent円14,291 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
CI Medical Co's net issuance of preferred for the
six
months ended in Jun. 2025 was 円0 Mil.
CI Medical Co paid円0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
CI Medical Co's cash flow for dividends for the
six
months ended in Jun. 2025 was 円-626 Mil.
CI Medical Co spent円626 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
CI Medical Co's other financing for the
six
months ended in Jun. 2025 was 円-6 Mil.
CI Medical Co spent円6 Mil on other financial activities.
CI Medical Co Cash Flow from Financing Related Terms
CI Medical Co Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for CI Medical Co's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CI Medical Co Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
CI Medical Co's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-16,369 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of 円-16,369 Mil mean?
CI Medical Co (TSE:3540) has a Cash Flow from Financing of 円-16,369 Mil as of Jun. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for CI Medical Co and its competitors.
Is CI Medical Co's Cash Flow from Financing too high?
CI Medical Co's current Cash Flow from Financing is 円-16,369 Mil. Overall, CI Medical Co has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does CI Medical Co's Cash Flow from Financing compare to PG and CL?
CI Medical Co's Cash Flow from Financing of 円-16,369 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Consumer Packaged Goods company?
A good Cash Flow from Financing depends on the Consumer Packaged Goods industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for CI Medical Co and its competitors. CI Medical Co's current Cash Flow from Financing is 円-16,369 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CI Medical Co stock overvalued right now?
CI Medical Co (TSE:3540) has a current Cash Flow from Financing of 円-16,369 Mil. The stock's GF Value™ is 円2,121.23, compared to a current price of 円1,492.00 — trading 29.7% below its estimated fair value. The current Cash Flow from Financing is 円-16,369 Mil. CI Medical Co's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For CI Medical Co (TSE:3540), the current Cash Flow from Financing is 円-16,369 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CI Medical Co (TSE:3540) Overvalued in 2026?
Based on GuruFocus' analysis, CI Medical Co stock appears to be undervalued.
The current stock price of 円1,492.00 is trading 29.7% below its estimated GF Value™ of 円2,121.23.
Key valuation signals for TSE:3540:
Cash Flow from Financing: 円-16,369 Mil
GF Value™: 円2,121.23 vs. price of 円1,492.00 (29.7% below fair value)
No single metric tells the full story. See the TSE:3540 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CI Medical Co Ltd engages in the development, manufacturing, and sales of dental care products. It operates 3D design labs; it offers advertising and marketing services through its website "Dental Mall" and also manages oral health care website "Ci Mall" and "Dental Fit" through which it sells oral health products and dentures. It serves medical cooperatives, dental clinics, dental associations, health centers, dental colleges, veterinary clinics, nursing home care facilities, and dental dealers.
70GF Score
Get the complete analysis for TSE:3540
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3540 has been successfully added to your 
